Drug reference
metformin-pioglitazone
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Endocrine (Insulin sensitizers)
Mechanism of action
Metformin: Biguanide; acts by decreasing endogenous hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Pioglitazone: Thiazolidinedione; insulin-sensitizing agent that acts by enhancing peripheral glucose utilization
Common side effects
- Dizziness
- Nausea
- Lower limb edema
- Weight gain
- Diarrhea
Related conditions
Frequently asked questions
What drug class is metformin-pioglitazone?
metformin-pioglitazone belongs to: Endocrine.
How does metformin-pioglitazone work?
Metformin: Biguanide; acts by decreasing endogenous hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Pioglitazone: Thiazolidinedione; insulin-sensitizing agent that acts by enhancing peripheral glucose utilization
What are the common side effects of metformin-pioglitazone?
Dizziness, Nausea, Lower limb edema, Weight gain, Diarrhea
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.